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Lithium-induced impairment of urine acidifcation. The purpose of
this study was to clarify the means by which lithium induced a
disorder of urine acidification. Rats infused with hydrochloric acid
(I mEq/kg) developed acute metabolic acidosis (blood pH = 7.32;
bicarbonate, 8 mEq/liter) with a urine pH of approximately 5.85.
The addition of lithium chloride (4 mEq/kg i.p.) caused an in-
crease in the urine p1-I (6.38) and a further decrease in blood
bicarbonate (11.0 mEq/liter). During bicarbonate loading, lithium
caused the urine Pco2 to fall significantly (urine minus blood Pco2
decreased from 25.3 + 2.8 to 14.4 2.3 mm Hg). These changes
were not seen following equimolar i.p. administration of sodium
chloride. Similarly, lithium administration depressed bicarbonate
reabsorption by 11.1% (from 30.6 to 27.2 iEq/ml of GFR) during
alkali infusion, while saline caused only a 5% decrease (30.0 to 28.5
pEq/rnl of GFR). The combination of an increase in urine pH and
bicarbonate excretion during acidosis and a decrease in urine Pco2
in alkaline urine indicates that lithium produced a defect in distal
nephron hydrogen ion secretion. The fall in bicarbonate reabsorp-
tion following lithium administration could be due to a mild hy-
drogen ion secretory defect located in the proximal tubule or a
severe defect in the distal nephron.
Alteration de l'acidification de l'urine induite par le lithium. Le
hut de ce travail est de melttre en evidence les mécanismes par
lesquels le lithium induit un dCsordre de l'acificiation des urines.
Des rats perfusCs avec de l'acide chlorhydrique (1 mEq/kg) déve-
loppent une acidose metabolique aiguë (p1-I sanguin = 7,32, hi-
carbonates plasmatiques 18 mEq/litre) avec un pH urinaire
voisin de 5,85. L'administration de chlorure de lithium (4 mhq/kg
i.p.) determine one augmentation du p1-I de l'urine (6,38) et une
diminution des bicarbonates plasmatiques (11,0 mEq/liter). Au
cours d'une charge de bicarbonate le lithium determine une dimi-
nution significative de Ia Pco2 de l'urine (Ia difference de Pco2
urine moms sang décroIt de 25,3 + 2,8 C 14,4 2,3 mm Hg). Ces
modifications ne sont pas observées si du sodium est administré C
Ia place du lithium, par voie intra-péritonéale et de facon équimo-
laire. L'administration de lithium déprime Ia reabsorption des
bicarbonates de I 1.1% (de 30,6 C 27,2 iEq/ml GFR) au cours
d'une perfusion alcaline alors qu'une perfusion saline ne deter-
mine qu'une diminution de 5% (30,0 a 28,5 mEq/ml GFR).
Lassociation dune augmentation du p1-I de lurine et d'une aug-
inentation de l'excrétion des bicarbonates au coors de l'acidose et
dune diminution de Ia Pco2 dans l'urine alcaline indique que le
lithium determine un deficit de Ia secretion distale d'ions H. La
diminution de Ia reabsorption des bicarbonates consecutive a
l'adniinistration de lithium peut être Ia consequence soit d'un
deficit modéré de secretion proximale d'ions I-U soit dun deficit
distal important.
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Lithium has been used in clinical medicine for
many years and the pharmacology of this agent has
been the subject of recent reviews [1, 2]. The kidneys
are an important target organ for the pharmacologic
actions of lithium and, indeed, fluid and electrolyte
disturbances are among the common reported side
effects. Usually the patients present with a vaso-
pressin-resistant diabetes insipidus [3—6], but lithium
can also cause disorders in urinary acidification
[7—Il]. The type of acidification defect and the
mechanism by which lithium exerts its effect have
not been fully evaluated and are the subject of this
report. Our results confirm that lithium causes a
defect of urine acidification. The reduced urine minus
blood carbon dioxide pressure gradient—(U-B) Pco2
—induced by lithium is best explained by a decrease
in distal nephron hydrogen ion secretion [12]. The
decrease in renal bicarbonate reabsorption was not
of sufficient magnitude to establish the presence of
a lithium-induced abnormality of proximal tubule
hydrogen ion secretion.
Methods
Experimental protocol. Male Wistar rats (150 to
350 g) were obtained from Woodlyn Farms, Guelph,
Ontario. They were allowed free access to food (Pu-
rina Lab Chow) and water prior to the study (0900
hr). Rats were anesthetized with Inactin (90 mg/kg
i.p.). Intravenous infusions were administered into
the jugular vein and blood pressure was monitored by
a catheter inserted into the femoral artery connected
to a mercury manometer. Blood samples were ob-
tained from the femoral artery and collected into
heparinized capillary tubes. The urine for pH and
Pco2 was collected anaerobically into capillary tubes
via a catheter (PE 190) placed suprapubically in the
bladder. Urine for flow rates and all other indexes
was collected into pre-tared vessels. The pH and Pco2
analyses were performed immediately after the sam-
ples were obtained.
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Acute metabolic acidosis studies. Rats were pre-
pared as described in the experimental protocol.
Rats were given 1000 Eq of Hf/kg (as 0.08N
hydrochloric acid in half-normal saline) into the
jugular vein over a 100-mm period to achieve the
desired degree of acidemia. After acid infusion, the
hydrochloric acid was replaced by hypotonic saline
(125 mEq/liter) for 60 to 120 mm during which the
control values were obtained prior to lithium or so-
dium chloride administration. Urine samples and one
to two blood samples were analyzed for pH and Pco2
before and after the dose of lithium.
Urine minus blood Pco2 studies. Sodium bi-
carbonate (2% wt/vol) and glucose (5% wt/vol)
were added to the drinking water of the rats for one
to two days preceding the experiment. Following the
induction of anesthesia, sodium bicarbonate (100 to
150 mEq/liter) was infused at a rate of 60 to 100
itl/min and continued throughout the experiment.
The rate of i.v. administration of fluid was adjusted
to give initial urine flow rates of greater than 20
#1/mm and urine pH exceeding 7.4. Two to four
urine samples were then collected anaerobically for
pH and Pco2 determinations before and after the i.p.
administration of lithium chloride (4 mEq/kg). Only
urine samples with a pH exceeding 7.4 and not pre-
ceded by an acid urine were selected, because mixing
of acid and alkaline urine would result in a high urine
Pco2 not reflecting increased distal nephron hydro-
gen ion secretion [12—14]. Sample collection periods
were approximately 5 to 20 mm in duration. Sodium,
potassium and phosphate concentrations were meas-
ured on each urine sample. At least one blood sample
was taken at the midpoint of the control and experi-
mental periods. Control animals received an equiva-
lent dose of sodium chloride administered i.p.
Tubular reabsorption of bicarbonate studies. The
rats were prepared as described above. Tritium-la-
belIed inulin was added to the i.v. administered fluids
in order to measure glomerular filtration rate (GFR).
A priming dose of 5 #Ci was followed by a sustaining
infusion of 6 #Ci/hr. Ten to twenty #1 samples of
blood and urine were taken for counting in two to
four periods before and immediately after the admin-
istration of lithium chloride or sodium chloride (4
mEq/kg, i.p.). Samples of blood and urine were also
analyzed for pH, Pco2 and bicarbonate.
Phosphate infusion studies. The rats were prepared
as described for the urine minus blood Pco2 studies
and the remainder of the protocol was performed as
described in the tubular reabsorption of bicarbonate
studies. Neutral phosphate (I to 2 #moles/min) was
infused i.v. coincident with the lithium chloride ad-
ministration. This insured equivalent phosphate ex-
cretion in control and experimental periods. The bi-
carbonate infusion was continued throughout. The
remainder of the experimental protocol was per-
formed as above.
Analytical methods. The blood and urine samples
for pH and Pco2 were measured on a digital acid-
base analyzer (Radiometer, model PHM72) at the
time of collection. Blood bicarbonate values were
calculated from the pH and Pco2 using a pK' of 6.1
and a value of 0.0301 for a. Urine bicarbonate was
calculated from the urine pH and Pco2 using a pK'
derived from the following formula: pK = 6.33 — 0.5
/71 [15]. Blood and urine electrolytes and inorganic
phosphorus were measured by standard techniques as
previously described [12]. Ammonium was deter-
mined by formal titration [16]. Tritium was measured
by liquid scintillation using a liquid scintillation
counter (Beckman LS 230) [17]. Statistical analyses
were performed using a paired t test within groups.
The changes between the sodium chloride group and
lithium chloride group were compared using an un-
paired t test. The mean pH was determined by ob-
taining the arithmetic mean of the hydrogen ion con-
centration and then converting back to pH units.
Materials and supplies. All chemicals used were of
analytical grade. Lithium chloride was obtained from
British Drug House Chemicals, Ltd., Poole, England.
Tritium-labelled inulin was from New England Nu-
clear, Boston, MA. mactin was obtained from Hen-
ley and Co., Inc., New York, NY. Carbon dioxide:
oxygen gas mixtures were obtained from Gas Dy-
namics, Ltd., Toronto, Canada and the composition
established by analysis. Reference buffers were ob-
tained from Radiometer, Copenhagen, Denmark.
Results
Acute metabolic acidosis studies (Table 1). Meta-
bolic acidosis was produced in 14 rats by the infusion
of approximately I mEq of hydrochloric acid/kg of
body wt. The in fusion was then changed to hypotonic
sodium chloride for 60 to 120 mm in order for the
acid-base values to stabilize. During this period, the
blood pH averaged 7.32; the blood bicarbonate, 18
mEq/liter; and the mean urine pH ranged from 5.72
to 5.98. Net acid excretion was approximately 1.4
#Eq/min and the urine contained very little bicarbo-
nate. Thirty minutes after the acute dose of lithium
chloride was administered (4 mEq i.p./kg of body
wt), the urine pH and bicarbonate excretion rose
significantly and this was accompanied by a signifi-
cant fall in ammonium and titratable acid excretion.
In some samples, the urine Pco2 rose, probably re-
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Table 1. Effect of lithium chloride on blood and urine acid-base indexes in hydrochloric acid-loaded ratsa
Index
Sodium chloride gro up (N 7) Lithium chloride group (N = 7)
Control NaCI Control LiCI
Blood
pH 7.31 0.01 7.27 + 0.02 7.32 + 0.01 7.23 0.02b
Pco2, mmHg 35.6 1.2 29.7 l.7c 36.8 + 0.9 26.3 l.4c
HCO, mEq/Iiter 17.6 0.4 13.6 l.2c 18.5 0.5 11.0 + 0.6e
U rifle
pH 5.98 + 0.06 5.80 O.07c 5.72± 0.10 6.38 + 0.l2c,e
Flow, /21/mm 13.9 2.0 10.9 + 2.3 23.7 5.1 28.2 8.9
U HCO.V,nEq/rnin 18.3 3.3 8.3 + 2.5 21.5 7.5 149.1 60.8d
UTA.V,nEq/min 451 86 398 93 629 34 135 + 29
U NH.V,nEq/min 996 + 170 625 + I l9' 767 132 357 94k'
U H.V,nEq/mmn 1429 + 226 1014 + 197C 1375 + 255 344 95
aAcute metabolic acidosis was induced by infusion of hydrochloric acid. After two to four collection periods, lithium chloride or
sodium chloride (4 mEq/kg) was administered i.p. Results are reported as mean SEM. Each individual value is the mean of the two to
four collection periods.
p < 0.05 for paired values.C < 0.01 for paired values.
p < 0.05 for comparison of changes due to sodium chloride with those duc to lithium chloridc.
ep < 0.01 for comparison of changes due to sodium chloride with those due to lithium chloride.
fleeting mixing of acid and alkaline urine [12—14].
The blood bicarbonate concentration decreased
significantly to 11.0 mEq/liter. In contrast, when
equimolar sodium chloride was administered instead
of lithium chloride, the urine pH and bicarbonate
excretion fell despite blood acid-base values similar
to those following lithium.
Urine minus blood Pco2 studies (Table 2). When
rats were infused with sodium bicarbonate (115 to
150 .sEq/ml, 100 p1/mm), the blood pH exceeded
7.50, and the bicarbonate, 32 mEq/liter. The urine
pH was greater than 7.60 with a PCO2 of 62 mm Hg.
The resulting (U-B) Pco2 was 25.3 + 3.3 and 25.3 +
2.8 mm Hg for the control periods of the sodium
chloride and lithium chloride groups, respectively.
After the i.p. administration of sodium chloride (4
mEq/kg), there was a rise in blood pH and no signifi-
cant change in any of the other above indexes. In
contrast, lithium chloride administration resulted in a
significant fall in both the blood pH and bicarbonate
concentration and the urine pH, bicarbonate, Pco2
and phosphate concentrations. The resultant (U-B)
PCO2 was significantly reduced to 14.4 + 2.3 mm Hg.
Factors which might influence the (U-B) Pco2 (Ta-
bles 3 and 4). The (U-B) Pco2 can be influenced by the
rate of bicarbonate and phosphate excretion or urine
Table 2. Effect of sodium chloride and lithium chloride on blood and urine acid-base indexes in bicarbonate-loaded rats°
Index
Sodium chloride group (N = 10) Lithium chloride group (N =, 21)
Control NaCl Control LiCl
Blood
pH 7.59 0.01 7.63 0.02b 7.51 0.02 7.48 + 0.03"
Pco2, rn/n Hg 34.3 1.7 32.3 + 2.3 40.1 1.4 33.6 1//b
HCO ,mEq/liter 33.6 1.9 33.3 + 2.1 32.5 + 1.6 25.8 I 75,e
Hct 39.9 2.3 38.0 2.3k 38.5 2.3 37.8 2.7
Urine
Flow, /51/mm 78 16 65 16 64 9.5 47 7.3
pH 7.69 0.03 7.77 + 0.03 7.67 0.02 7.62 0.03c
Pco2, mm Hg 59.5 + 3.1 59.7 3.2 64.6 2.5 48.2 2.l"
HCO.V,uEq/rnin 6.0 1.5 7.4 2.0 5.2 0.6 3.1 + 0.5
P04.v,nmoles/min 1837 486 1600 243 1035 + 194 385 + 56b
(U—B) Pco2, mm Hg 25.3 + 3.3 28.3 3.0 25.3 2.8 14.4 2.3"
For details of the experiment see urine minus blood Pco2 in Methods section. Results are reported as mean + SEM for each index, the
value in each rat representing the mean of two to four samples in collection periods between 30 and 90 mm after sodium or lithium
chloride administration. Urine phosphate excretion was determined in six of ten sodium chloride-treated rats and all the lithium chloride-
treated rats.
bP < 0.01 for paired observations.
"P < 0.05 for comparison of changes due to sodium chloride with those due to lithium chloride.
d < 0.01 for comparison of changes due to sodium chloride with those due to lithium chloride.
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Table 3. Effect of bicarbonate excretion rate, urine flow rate and
urine phosphate on the (U—B) Pco2a
Group Index Control LiCI
A Rate of bicarbonate
excretionb, tEq/min
(U-B) Pco2, mm Hg
2.45 + 0.33
25.8 3.2
2.74 0.25
14.9 + 3.l
B Urine flow/GFRC,
/21/mi GFR
(U—B) Pco2, mm Hg
22.9 4.3
27.2 + 2.4
29.3 + 7.2
10.9 + 33f
C Phosphated, nmoles/min
(U-B) Pco2, mm Hg
2020 530
36.2 + 5.4
2120 + 520
22.3
a Results are reported as mean SEM. The number of rats was 8
in the control and 10 after lithium in group A, 17 for the control
and 6 after lithium in group B, and 6 for the control and lithium
groups in group C.
5Results are derived from Table 2 and include only those rats
which had a rate of bicarbonate excretion from 1.5 to 4.0 /1Eq/min.
cResults are derived from Table 4 and include only those rats which
had a urine flow/GFR of 5 to 60 sl/min/ml.
dFor details of the experiment, see phosphate infusion in Methods
section.
ep < 0.05 for unpaired values.
1P < 0.01 for unpaired values.
gp < 0.01 for paired values.
flow. In order to eliminate these factors as important
mechanisms by which lithium exerted its effect, data
were analyzed over a comparable range of these vari-
ables (Table 3). When the rate of bicarbonate excre-
tion was 1.5 to 4 tEq/min (mean, 2.45 before and
2.74 after lithium), the (U-B) Pco2 was 25.8 + 3.2
mm Hg in the control period and significantly reduced
to 14.9 + 3.1 mm Hg after lithium administration.
Similarly, when compared over a urine flow/ml of
GFR range of 5 to 60 p1/mm (mean, 22.9 before
and 29.3 after lithium), lithium caused the (U-B)
PCO2 to fall significantly from 27.2 2.4 to 10.9 3.3
mm Hg. Regression analysis failed to demonstrate
any dependency of the (U-B) Pco2 on either the rate
of bicarbonate excretion or flow/rn 1 of GFR before
and after lithium administration over the ranges
studied.
Phosphate excretion was decreased following lith-
ium chloride (Table 2). In order to eliminate this
variable as the cause for the fall observed in the (U-B)
Pco2, phosphate was infused coincident with lithium
administration at a rate of 1 to 2 smoles/min. This
infusion rate resulted in similar phosphate excretion
rates in the pre- and post-lithium periods. The (U-B)
Pco2 fell significantly from 36.2 + 5.4 to 22.3 2.9
mm Hg (Table 3).
Tubular reabsorption of bicarbonate studies (Table
4). As shown above, the infusion of sodium bi-
carbonate caused the blood pH to exceed 7.50 and
the bicarbonate to exceed 31 mEq/liter. The rate of
bicarbonate reabsorption was 69.6 + 14.7 and 80.2
13.1 Eq/min and when expressed per milliliter of
GFR was 30.0 0.84 and 30.6 + 0.81 tEq/ml of
GFR in the control periods of the sodium chloride
and lithium chloride experiments, respectively. After
the i.p. administration of sodium chloride (4
mEq/kg), there was no significant change in these
indexes although the bicarbonate reabsorption/mI of
GFR was reduced from 30.0 + 0.84 to 28.5 + 1.52, a
mean fall of 5%. In contrast, i.p. administration of
lithium chloride caused a significant reduction in
both the blood bicarbonate concentration and the
rate of bicarbonate reabsorption/mi of GFR. The
bicarbonate reabsorption after lithium was 27.2 +
Table 4. Effect of sodium chloride and lithium chloride on bicarbonate reabsorption in bicarbonate-loaded ratsa
Index
Sodium chloride group (N = 6) Lithium chloride group (N = 17)
Control NaCI Control LiCl
Blood
pH 7.61 0.01 7.62 0.02 7.57 + 0.02 7.55 0.01
Pco2, mm Hg 33.0 + 0.8 29.0 0.2k 35.8 + 0.9 35.0 l.5
I-1C03, mEq/Iiter 31.7 + 0.5 29.4 + 1.2 32.5 + 0.7 29.8 + 12b
Hct 45.5 + 1.0 43.1 + I.0 43.6 + 1.0 40.9 l.2b
Urine
GFR, mi/mm/body WI 2.44 + 0.44 2.89 + 0.66 2.62 + 0.38 2.25 + 0.43
Flow, /21/mm 39.8 + 13.1 29.0 + 6.7 54.4 + 8.9 65.1 14.4
HCO3- X V. /2Eq/min 2.05 + 0.49 1.95 0.63 4.86 + 1.16 5.73 1.71
HCO3- reabsorption, uEq/min 69.6 14.7 82.9 + 20.4 80.2 13.1 66.0 13.9
HCO3 reabsorption/mI 30.0 0.84 28.5 1.52 30.6 0.81 27.2 1•06b
of GFR
aFor details of the experiment, see Methods section. Results are reported as mean SEM for each index, the value in each rat representing
the mean of two to four collection periods.
p < 0.01 for paired observations.
< 0.05 for comparison of changes due to sodium chloride with those due to lithium chloride.d < 0.01 for comparison of changes due to sodium chloride with those due to lithium carbonate.
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1.06 Eq/m1 of GFR, 11.1% lower than the control
value.
Discussion
In humans, upon induction of a metabolic acidosis,
the urine pH characteristically falls below 5.30 [18].
Rats, on the other hand, are unable to achieve these
low urine pH's despite significant acidemia [19—22].
This is generally attributed to the higher urinary am-
monia excretion in the rat. In our studies as well, the
urine pH was approximately 5.85 during metabolic
acidosis induced with hydrochloric acid (Table I).
Despite this metabolic acidosis, lithium chloride in-
duced bicarbonaturia, an increase in urine pH to 6.38
and a decrease in net acid excretion. This change in
urine acidification could not be attributed to an in-
crease in extracellular fluid volume as rats treated in
an identical manner, but given sodium chloride in-
stead of lithium chloride, demonstrated no increase
in urine pH or bicarbonate excretion (Table 1). (A
fall in ammonia excretion and urine pH after acute
sodium chloride administration has been noted pre-
viously [23].) Therefore, lithium induced a defect in
urine acidification which could not be abolished by
markedly lowering the plasma bicarbonate. This
suggests the presence of a defect in distal nephron
net hydrogen ion secretion. The severity of the
acidification defect was not as marked, as noted by
Sirota, Forrest and Epstein [10]. In their study, the
urine p1-I rose to 7.99. However, the results presented
arc qualitatively similar to those reported by other
investigators [7—I I].
In order to determine if a defect in distal hydrogen
ion secretion was produced as a result of lithium
administration, the urine minus blood Pco2 gradient
was measured [12]. Hydrogen ions secreted into the
bicarbonate-containing distal tubular fluid will result
in the formation of carbonic acid. As there is no
luminal carbonic anhydrase in the distal nephron
[24], the dehydration of carbonic acid is delayed until
arrival in the lower urinary tract where the surface
area-to-volume ratio retards carbon dioxide reab-
sorption. Urine carbon dioxide is thus derived from
two major sources, one as a result of distal nephron
hydrogen ion secretion into alkaline urine and the
other from equilibration of the urine Pco2 with the
Pco2 of the renal parenchyma. As this latter value is
best reflected by the blood Pco2 [25], the (U-B) Pco2
is an indicator of distal nephron hydrogen ion secre-
tion. Normal rats [26, 27], as humans [12, 13, 28,
29], had an elevated (U-B) Pco2 when excreting
alkaline urine (Tables 2 and 3). However, following
administration of lithium, the (U-B) Pco2 fell to ap-
proximately one-half the control level within 30 to 90
mm. In contrast, sodium chloride administration had
no effect on the (U-B) Pco2. Thus, distal nephron
acidification was impaired by lithium in a manner
analogous to that seen in distal renal tubular acidosis
[12].
Although the (U-B) Pco2 has been used as an index
of distal nephron hydrogen ion secretion, several cri-
teria must be met in order to interpret these data with
confidence. An increase in phosphate excretion due
to phosphate infusion results in an increase in (U-B)
Pco2 [14, 28, 29]. Thus, it is conceivable that a decline
in phosphate excretion could decrease the (U-B)
Pco2. To examine this possibility we infused phos-
phate coincident with lithium chloride administration
to ensure equivalent phosphate excretion rates before
and after lithium. The results demonstrated a signifi-
cant decline in (U-B) Pco2 (Table 3). Other factors
known to influence the urine Pco2 are the rate of
bicarbonate excretion and urine flow rate (or flow/ml
of GFR). Examination of our data at comparable
rates of bicarbonate excretion and urine flow/ml of
GFR before and after lithium administration estab-
lished that these factors could not account for the
lithium-induced fall in (U-B) Pco2 (Table 3).
We interpret the decrease in (U-B) Pco2 to be
evidence for a decrease in distal nephron hydrogen
ion secretion [12]. The lithium-induced decrease in
water permeability of this segment of the nephron in
the presence of antidiuretic hormone [3—6] and
dibutyryl cyclic adenosine monophosphate [61
parallels the defect of urine acidification. Increased
permeability of this segment of the nephron to
H2C03, despite water impermeability, could also
be responsible for the lesion of distal renal tubu-
lar acidosis [30] and be consonant with the above
results. We consider this explanation to be less likely
[12, 31].
The possibility of a coexistent defect in proximal
tubular hydrogen ion secretion was suggested by the
degree of bicarbonaturia in the presence of acidemia
(Table 1) and the prompt fall in serum bicarbonate
following lithium chloride (Tables 1, 2 and 4). In
order to define whether proximal renal tubular acid-
osis was present, the rate of bicarbonate reabsorption
was determined before and after the administration
of lithium. Lithium caused a 11.1% fall in the tubular
reabsorption of bicarbonate when expressed per mil-
liliter of GFR (Table 4). To examine the possibility
that lithium depressed bicarbonate reabsorption by
expanding the extracellular fluid volume, an equimo-
lar quantity of sodium chloride was administered
instead of the lithium chloride. Sodium chloride ad-
ministration depressed the tubular reabsorption of
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bicarbonate by approximately 5%. This fall was not
statistically significant, and may have been due to a
decline in the blood Pco2. It is possible, therefore,
that lithium did induce a fall in proximal bicarbonate
reabsorption independent of extracellular fluid vol-
ume expansion, but this cannot be confirmed at the
dose of lithium used, as the lithium-induced fall does
not exceed 15% [32, 33]. Similarly, recalculation of
the data presented by Arruda, Richardson and Kurtz-
man [34] shows that bicarbonate reabsorption was
similar in lithium-treated and control dogs. The
results of Sirota et a! [10] suggest a decreased bi-
carbonate reabsorption in that the urine pH rose to
7.99 after lithium administration. However, one can-
not conclude that a proximal renal tubular acidosis
was present from their data.
A small decline in GFR was noted in most experi-
ments after acute lithium administration (Table 4).
Therefore, the question might be raised as to whether
the decreased (U-B) Pco2 could have been due to an
acute decline in the GFR. This seems unlikely as
Thompson and Barret noted no decrease in the (U-B)
Pco2 when the GFR was reduced by acute con-
striction of the aorta with a balloon catheter [35].
Similarly, studies in our laboratory demonstrated
that there was no change in the (U-B) Pco2 when
the GFR was reduced by 13 to 75% by either nitro-
prusside infusion or by acute partial ureteral con-
striction [36]. Furthermore, the reduction in GFR
in our lithium experiments is not statistically signifi-
cant and the decline in (U-B) Pco2 occurred regard-
less of whether the GFR fell or not.
In summary, lithium caused a diminished (U-B)
Pco2. The most likely explanation for these results is
a decreased distal nephron hydrogen ion secretion.
The presence of definite evidence for a distal defect in
hydrogen ion secretion in the absence of a clear-cut
proximal abnormality may reflect either a greater
sensitivity of this segment of the nephron to the phar-
macologic actions of lithium or that this agent is
delivered to the distal nephron cells at a higher con-
centration [6]. Lithium might cause a more severe
distal than proximal lesion as the luminal lithium
concentration should be higher in the distal than in
the proximal nephron segment owing to the progres-
sive water reabsorption.
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